IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
